Stoke Therapeutics, Inc. ( STOK) - Key Metrics
STOK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.14 | -$0.93 | -$0.86 | -$0.89 |
| 2026Q1 | $0.10 | -$0.79 | -$0.96 | -$0.97 |
| 2025Q4 | $0.02 | -$0.99 | -$0.52 | -$0.53 |
| 2025Q3 | $0.18 | -$0.65 | -$0.52 | -$0.52 |
| 2025Q2 | $0.24 | -$0.40 | -$0.44 | -$0.44 |
STOK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.80 |
| 2026Q1 | 0% | -10.30 |
| 2025Q4 | 0% | -8.02 |
| 2025Q3 | 0% | -9.04 |
| 2025Q2 | 0% | -7.09 |
STOK
Price: $31.27
52 week price:
Earnings Per Share: -3.39 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 66686
Market Capitalization: 2.1 billion